Cambridge, United Kingdom

David Buttar

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: David Buttar - Innovator in Cancer Treatment

Introduction

David Buttar is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 2 patents, his work is recognized for its potential impact on medical science.

Latest Patents

One of David Buttar's latest patents involves Triazolopyrimidine compounds and their use in treating cancer. This invention concerns compounds of Formula (I), which are designed to provide new therapeutic options for cancer patients. His innovative approach aims to enhance the efficacy of cancer treatments.

Career Highlights

Throughout his career, David has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Dizal Pharmaceutical Co., Ltd. and Dizal Pharmaceutical Co., Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

David Buttar has collaborated with several professionals in his field, including Frederick Woolf Goldberg and Attilla Kuan Tsuei Ting. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer treatment.

Conclusion

David Buttar's contributions to the field of cancer treatment through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…